An in vitro Model System for Evaluating Remote Magnetic Nanoparticle Movement and Fibrinolysis

BACKGROUND: Thrombotic events continue to be a major cause of morbidity and mortality worldwide. Tissue plasminogen activator (tPA) is used for the treatment of acute ischemic stroke and other thrombotic disorders. Use of tPA is limited by its narrow therapeutic time window, hemorrhagic complication...

Descripción completa

Detalles Bibliográficos
Autores principales: Pernal, Sebastian P, Willis, Alexander J, Sabo, Michael E, Moore, Laura M, Olson, Steven T, Morris, Sean C, Creighton, Francis M, Engelhard, Herbert H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071866/
https://www.ncbi.nlm.nih.gov/pubmed/32210551
http://dx.doi.org/10.2147/IJN.S237395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071866/
https://www.ncbi.nlm.nih.gov/pubmed/32210551
http://dx.doi.org/10.2147/IJN.S237395

Ejemplares similares